DYNE THERAPEUTICS INC. - COMMON STOCK
29.83
25-11月-24 14:30:12
15 分の遅延
株式
+0.14
+0.47%
本日の幅
29.19 - 30.77
ISIN
N/A
ソース
NASDAQ
-
Dyne Therapeutics to Present at Stifel 2024 Virtual CNS Days
13 3 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
05 3 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
Dyne Therapeutics to Present at February Investor Conferences
01 2 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
11 1 2024 16:05:00 提供 Nasdaq GlobeNewswire
-
Dyne Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference
05 1 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
Dyne Therapeutics Announces Pricing of $300 Million Public Offering of Common Stock
04 1 2024 22:46:36 提供 Nasdaq GlobeNewswire
-
Dyne Therapeutics Announces Proposed Public Offering of Common Stock
03 1 2024 16:25:00 提供 Nasdaq GlobeNewswire
-
02 1 2024 16:05:00 提供 Nasdaq GlobeNewswire
-
Dyne Therapeutics to Present at November Investor Conferences
07 11 2023 07:30:00 提供 Nasdaq GlobeNewswire
-
30 10 2023 07:30:00 提供 Nasdaq GlobeNewswire
-
Dyne Therapeutics to Present at October Investor Conferences
28 9 2023 07:30:00 提供 Nasdaq GlobeNewswire
-
20 9 2023 16:05:00 提供 Nasdaq GlobeNewswire
-
Dyne Therapeutics to Present at Morgan Stanley 21st Annual Global Healthcare Conference
05 9 2023 07:30:00 提供 Nasdaq GlobeNewswire
-
Dyne Therapeutics Reports Second Quarter 2023 Financial Results and Business Highlights
03 8 2023 07:30:00 提供 Nasdaq GlobeNewswire
-
Dyne Therapeutics to Present at Jefferies Healthcare Conference
01 6 2023 07:30:00 提供 Nasdaq GlobeNewswire
-
Dyne Therapeutics Receives European Medicines Agency (EMA) Orphan Drug Designation for DYNE-101
25 5 2023 07:30:00 提供 Nasdaq GlobeNewswire
-
17 5 2023 07:30:00 提供 Nasdaq GlobeNewswire
-
Dyne Therapeutics Reports First Quarter 2023 Financial Results and Business Highlights
11 5 2023 07:30:00 提供 Nasdaq GlobeNewswire